Recent Finacing
Recent Raise
Umecrine Cognition develops GABAA receptor‑modulating steroid antagonists, including golexanolone and GR3027, and runs clinical trials for hepatic encephalopathy, primary biliary cholangitis and idiopathic hypersomnia.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Umecrine Cognition.
